LABORATORIOS FARMACEUTICOS ROVI, S.A. «...678910...» Page 8 out of 17 from 01/07/1988 to 09/10/2015 The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish 15/02/2012 12:57 LABORATORIOS FARMACEUTICOS ROVI, S.A. Changes in the investment policy, business areas and product lines Corlentor® receives approval for use in heart failure Register number: 158103 22/12/2011 13:04 LABORATORIOS FARMACEUTICOS ROVI, S.A. Composition of the board of directors La Sociedad informa sobre la dimisión de uno de sus Consejeros. Register number: 155338 21/12/2011 17:58 LABORATORIOS FARMACEUTICOS ROVI, S.A. Strategic agreements with third parties La Sociedad aclara Hecho Relevante 155287 anterior. Register number: 155301 21/12/2011 15:42 LABORATORIOS FARMACEUTICOS ROVI, S.A. Strategic agreements with third parties La Sociedad informa acerca de la autorización por parte de la Comisión Nacional de la Competencia de la operación consistente en la venta a Grupo Ferrer del 50% del capital social de Alentia Biotech, sociedad perteneciente a ROVI. Register number: 155287 08/11/2011 11:08 LABORATORIOS FARMACEUTICOS ROVI, S.A. Composition of other management and supervisory bodies La Sociedad informa sobre la composición del Comité de Auditoría y la Comisión de Nombramientos y Retribuciones. Register number: 152998 08/11/2011 07:56 LABORATORIOS FARMACEUTICOS ROVI, S.A. Information on P&L The Company releases the presentation related to the nine-month period ended 30 September 2011 results Register number: 152986 08/11/2011 07:53 LABORATORIOS FARMACEUTICOS ROVI, S.A. Interim financial information La sociedad remite información sobre los resultados del tercer trimestre de 2011 Register number: 152985 07/11/2011 12:48 LABORATORIOS FARMACEUTICOS ROVI, S.A. Others about corporate governance La Sociedad informa sobre la modificación de su Reglamento del Consejo de Administración. Register number: 152899 19/10/2011 08:24 LABORATORIOS FARMACEUTICOS ROVI, S.A. R&D: new licenses, patents and registered trademarks The Company publishes the press release related to the results of the final analysis of the "ABEL" Phase II clinical trial of Bemiparin in small cell lung cancer Register number: 151833 26/09/2011 11:16 LABORATORIOS FARMACEUTICOS ROVI, S.A. Strategic agreements with third parties The Company releases the press release related to the plans of Alentia Biotech, a joint venture of Ferrer and ROVI, for the construction of a national production centre to supply the Spanish population with flu vaccines. Register number: 150475 Page 8 out of 17 «...678910...»